HARMONY BIOSCIENCES CONTINUES COMMUNITY COMMITMENT IN 2023 WITH PATIENTS AT THE HEART AND PROGRESS AT THE HEART NONPROFIT FUNDING PROGRAMS
The annual funding programs support patient-centric initiatives within rare neurological disease and sleep disorder communities
Applications for Patients at the Heart and Progress at the Heart open today,
The annual programs have supported diverse initiatives ranging from a retreat to provide rare disease caregivers with new skills to care for their loved ones and develop their own self-care practices to a behavioral and educational program for underrepresented high school students to raise awareness of the importance of healthy sleep for the prevention of cardiovascular and other chronic diseases.
Both the Patients at the Heart and Progress at the Heart funding programs provide opportunities for organizations providing innovative, comprehensive, and patient-centric initiatives that either directly support the unique challenges and profound needs of people living with sleep disorders and rare neurological diseases who experience excessive daytime sleepiness (EDS) or help achieve greater equality within rare neurological disease communities.
"People living with sleep disorders often face stigma from a lack of understanding about their diagnosis and the needs that follow," said
"Achieving lasting equality across sleep disorder communities starts with developing effective positive educational messaging to racially and ethnically diverse individuals, including adolescents," said
Funding applications for both programs in 2023 open on
2023 Patients at the Heart Program Information
Since its inception in 2019, the Patients at the Heart program underscores Harmony's ongoing commitment to support the comprehensive needs of people affected by rare neurological diseases. Applications for 2023 and submission information can be accessed at: https://www.harmonybiosciences.com/funding-programs/patients-at-the-heart/.
2023 Progress at the Heart Program Information
Sleep health disparities are impacted by ethnicity, socioeconomic status, discrimination, geography, social patterns, and access to healthcare, as well as other complicating factors. Since 2021, the Progress at the Heart program has funded innovative programs that address disparities, injustice, and inequities in the rare neurological disease and sleep disorder communities. Applications for 2023 and submission information can be accessed at: https://www.harmonybiosciences.com/funding-programs/progress-at-the-heart/.
Applicants must be a 501(c)(3) or similarly credentialed nonprofit organization and applications will be reviewed by a cross-functional team of
Harmony Biosciences Media Contact:
Harmony Biosciences Investor Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-continues-community-commitment-in-2023-with-patients-at-the-heart-and-progress-at-the-heart-nonprofit-funding-programs-301756734.html